查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463062

急性復发性癫痫市场、占有率、规模、趋势、产业分析报告：依产品、最终用途、地区和细分市场预测，2024-2032 年

Acute Repetitive Seizures Market Share, Size, Trends, Industry Analysis Report, By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel, Others); By End Use; By Region; And Segment Forecasts, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球急性復发性癫痫市场规模预计将达到 79.4 亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

市场成长背后的驱动力是临床研究的增加、对新药推出的日益关注以及对用于癫痫治疗的鼻喷剂的需求不断增长。 此外，越来越多的监管批准和正在开发的有前景的治疗方法预计也将在预测期内推动急性復发性癫痫市场的发展。 在努力控制医疗保健成本的同时，各国政府正在积极努力，透过引入家庭医疗保健和诊所等门诊护理模式，最大限度地降低住院和现场治疗的成本。

孤儿药可望透过大规模商业化主导全球市场。 USL-261 和 VALTOCO 的孤儿药资格表明定价可能会上涨。 此外，与其他给药方法相比，对鼻腔给药途径的偏好也预计将有助于这两种药物的使用增加。 对安全且具有成本效益的药物替代品的需求不断增长，促使评估透过鼻喷雾剂鼻内给药的安全性和有效性的临床试验激增。 此外，随着FDA批准数量的不断增加，创新药物预计很快就会推出，为急性復发性癫痫市场提供新的成长机会。

欧洲的成长是由神经学研究和开发投资的增加以及癫痫药物需求的增加所推动的。 此外，科学、治疗和医学方面的技术进步也可能促进这一增长。 同时，旨在提高生活品质、提高疾病意识和改善医疗设施的政府措施是推动该地区市场扩张的关键因素。

包括新兴国家在内的世界各国政府正积极推动医疗改革，以因应不断上涨的医疗费用。 这些改革的一个重要方面是透过引入诊所和家庭医疗保健等门诊护理模式来减少住院时间和现场治疗费用。 这种方法背后的基本原理是使医疗保健服务更具成本效益、更方便且以患者为中心。 医疗改革可以提高治疗的可近性，减轻医院资源的压力，并改善病患的治疗结果。 随着新兴国家政府专注于实施此类改革，门诊护理模式的成长预计将透过提供更有效率、更具成本效益的患者照护方式来推动市场扩张。

急性復发性癫痫市场报告重点

USL-261 将在 2023 年占最大的市场占有率，由于易于管理，使其成为治疗包括 ARS 在内的急性发作群体的有吸引力的选择

医疗保健和製药行业预计在预测期内将以最快的复合年增长率增长，有利的监管政策和市场批准将促进创新疗法的商业化并促进市场增长。

北美尤其是美国的监管环境有利于医疗保健产业的创新和市场拓展。 美国食品药物管理局 (FDA) 等监管机构为 ARS 治疗的开发和批准提供了明确的指导方针和途径，促进了市场成长。

预计亚太地区在预测期内将以最快的复合年增长率成长。 对医疗基础设施的关注和对癫痫的认识的提高是新兴市场成长的有利条件。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第 4 章急性复发性癫痫全球市场洞察

  • 急性復发性癫痫市场 - 产业概况
  • 急性復发性癫痫市场动态
    • 推动者和机会
      • 神经系统疾病盛行率的上升预计将推动市场成长
      • 全世界癫痫发生率的增加直接导致了 ARS 盛行率的增加。
    • 抑制因素和课题
      • 专业诊断测试和监测设备的可用性有限
  • 杵分析
  • 急性復发性癫痫产业的趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第 5 章依产品划分的世界市场

  • 主要发现
  • 简介
  • USL-261
  • NRL-1
  • AZ-002
  • Diastat直肠凝胶
  • 其他

第 6 章以最终用途划分的全球市场

  • 主要发现
  • 简介
  • 生物技术
  • 医疗保健和製药
  • 其他

第 7 章依地区划分的世界市场

  • 主要发现
  • 简介
    • 2019-2032 年急性復发性癫痫市场评估（依地区）
  • 急性復发性癫痫市场 - 北美
    • 北美：急性復发性癫痫市场，依最终用途划分，2019-2032 年
    • 北美：急性復发性癫痫市场（依产品），2019-2032 年
    • 急性復发性癫痫市场 - 美国
    • 急性復发性癫痫市场 - 加拿大
  • 急性復发性癫痫市场 - 欧洲
    • 欧洲：2019-2032 年急性復发性癫痫市场（依最终用途）
    • 欧洲：急性復发性癫痫市场（依产品），2019-2032 年
    • 急性復发性癫痫市场 - 英国
    • 急性復发性癫痫市场 - 法国
    • 急性復发性癫痫市场 - 德国
    • 急性復发性癫痫市场 - 义大利
    • 急性復发性癫痫市场 - 西班牙
    • 急性復发性癫痫市场 - 荷兰
    • 急性复发性癫痫市场 - 俄罗斯
  • 急性復发性癫痫市场 - 亚太地区
    • 亚太地区：急性復发性癫痫市场，依最终用途，2019-2032 年
    • 亚太地区：急性復发性癫痫市场（依产品），2019-2032 年
    • 急性復发性癫痫市场 - 中国
    • 急性復发性癫痫市场 - 印度
    • 急性復发性癫痫市场 - 马来西亚
    • 急性復发性癫痫市场 - 日本
    • 急性復发性癫痫市场 - 印度尼西亚
    • 急性復发性癫痫市场 - 韩国
  • 急性復发性癫痫市场 - 中东和非洲
    • 中东和非洲：急性復发性癫痫市场（以最终用途），2019-2032 年
    • 中东和非洲：急性复发性癫痫市场（依产品），2019-2032 年
    • 急性復发性癫痫市场 - 沙乌地阿拉伯
    • 急性復发性癫痫市场 - 阿联酋
    • 急性復发性癫痫市场 - 以色列
    • 急性復发性癫痫市场 - 南非
  • 急性復发性癫痫市场 - 拉丁美洲
    • 拉丁美洲：急性復发性癫痫市场，依最终用途划分，2019-2032 年
    • 拉丁美洲：急性復发性癫痫市场（依产品），2019-2032 年
    • 急性復发性癫痫市场 - 墨西哥
    • 急性復发性癫痫市场 - 巴西
    • 急性復发性癫痫市场 - 阿根廷

第八章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 合作/协作/合约/出版物

第九章公司简介

  • ALEXZA
  • Alexza Pharmaceuticals
  • Bausch Health Companies Inc.
  • Neurelis, Inc.
  • Pfizer Inc.
  • Sanofi
  • UCB S.A. Belgium
  • Valeant Pharmaceuticals North America LLC.
  • VERITON PHARMA
Product Code: PM4747

The global acute repetitive seizures market size is expected to reach USD 7.94 billion by 2032, according to a new study by Polaris Market Research. The report "Acute Repetitive Seizures Market Share, Size, Trends, Industry Analysis Report, By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel, Others); By End Use; By Region; And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growth of the market is driven by an increasing number of clinical studies, a heightened focus on the introduction of new medicines, and a growing demand for nasal sprays as a treatment for epilepsy. Moreover, the upswing in regulatory approvals and promising treatments in the pipeline is anticipated to fuel the development of the acute repetitive seizures market over the projected period. In tandem with initiatives to curtail healthcare expenditure, governments are actively engaged in minimizing hospital stays and on-site treatment costs through the implementation of outpatient care models, including home healthcare and clinics.

Orphan drugs are anticipated to dominate the global market, driven by extensive commercialization. The designation of both USL-261 and VALTOCO as orphan drugs suggests that their pricing is likely to be elevated. Furthermore, the preference for the nasal route of administration over other methods is expected to contribute to the increased utilization of these two medications. The rising demand for safe and cost-effective alternatives has led to a surge in clinical trials assessing the safety and efficacy of nasal route administration through nasal sprays. Additionally, the increasing number of FDA approvals is expected to pave the way for the introduction of innovative medications soon, presenting new growth opportunities for the acute repetitive seizures market.

Europe's growth is attributed to heightened investment in neurology research and development, coupled with an increasing demand for epilepsy drugs. Additionally, advancements in technology within the scientific, therapeutic, and medical sectors are poised to contribute to this growth. Concurrently, government initiatives aimed at enhancing quality of life, raising awareness about the disease, and fostering improved healthcare facilities are the key drivers propelling market expansion in the region.

Governments worldwide, including emerging economies, are actively pursuing healthcare reforms to address rising healthcare costs. One significant aspect of these reforms involves reducing hospital stays and on-site treatment costs through the implementation of outpatient care models, such as clinics and home healthcare. The rationale behind this approach is to make healthcare services more cost-effective, accessible, and patient-centric. Healthcare reforms can lead to increased accessibility to treatment, reduced burdens on hospital resources, and improved patient outcomes. As governments in emerging economies focus on implementing such reforms, the growth of outpatient care models is expected to propel the expansion of the market by providing more efficient and cost-effective avenues for patient care.

Acute Repetitive Seizures Market Report Highlights

USL-261 segment held the largest market share in 2023, the convenience of administration makes USL-261 an attractive option for managing acute seizure clusters, including those characteristics of ARS

Healthcare & pharmaceuticals segment is expected to grow at the fastest CAGR during the forecast period, Favorable regulatory policies and market approvals facilitate the commercialization of innovative treatments, contributing to market growth.

North America region held the largest market share in 2023, The regulatory environment in North America, particularly in the United States, is conducive to innovation and market expansion in the healthcare sector. Regulatory agencies such as the Food and Drug Administration (FDA) provide clear guidelines and pathways for the development and approval of ARS treatments, facilitating market growth.

Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The increased focus on healthcare infrastructure and rising awareness about epilepsy contribute to the favorable conditions for market growth in these developing nations.

The global players include ALEXZA, Alexza Pharmaceuticals, Bausch Health Companies Inc., Neurelis, Inc., Pfizer Inc., Sanofi, UCB S.A. Belgium, Valeant Pharmaceuticals North America LLC., VERITON PHARMA.

Acute Repetitive Seizures Market Research has segmented the acute repetitive seizures market report based on product, end use, and region:

Acute Repetitive Seizures, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • USL-261
  • NRL-1
  • AZ-002
  • Diastat Rectal Gel
  • Others

Acute Repetitive Seizures, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Biotechnology
  • Healthcare & pharmaceuticals
  • Others

Acute Repetitive Seizures, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Acute Repetitive Seizures Market Insights

  • 4.1. Acute Repetitive Seizures Market - Industry Snapshot
  • 4.2. Acute Repetitive Seizures Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Neurological Disorders is projected to spur the market growth
      • 4.2.1.2. The rising incidence of epilepsy cases worldwide directly contributes to the increasing prevalence of ARS
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited availability of specialized diagnostic tests or monitoring devices
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Acute Repetitive Seizures Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Acute Repetitive Seizures Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Acute Repetitive Seizures, by Product, 2019-2032 (USD Billion)
  • 5.3. USL-261
    • 5.3.1. Global Acute Repetitive Seizures Market, by USL-261, by Region, 2019-2032 (USD Billion)
  • 5.4. NRL-1
    • 5.4.1. Global Acute Repetitive Seizures Market, by NRL-1, by Region, 2019-2032 (USD Billion)
  • 5.5. AZ-002
    • 5.5.1. Global Acute Repetitive Seizures Market, by AZ-002, by Region, 2019-2032 (USD Billion)
  • 5.6. Diastat Rectal Gel
    • 5.6.1. Global Acute Repetitive Seizures Market, by Diastat Rectal Gel, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Acute Repetitive Seizures Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Acute Repetitive Seizures Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • 6.3. Biotechnology
    • 6.3.1. Global Acute Repetitive Seizures Market, by Biotechnology, by Region, 2019-2032 (USD Billion)
  • 6.4. Healthcare & pharmaceuticals
    • 6.4.1. Global Acute Repetitive Seizures Market, by Healthcare & pharmaceuticals, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Acute Repetitive Seizures Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Acute Repetitive Seizures Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Acute Repetitive Seizures Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Acute Repetitive Seizures Market - North America
    • 7.3.1. North America: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.3.3. Acute Repetitive Seizures Market - U.S.
      • 7.3.3.1. U.S.: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.3.4. Acute Repetitive Seizures Market - Canada
      • 7.3.4.1. Canada: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • 7.4. Acute Repetitive Seizures Market - Europe
    • 7.4.1. Europe: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.3. Acute Repetitive Seizures Market - UK
      • 7.4.3.1. UK: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.4. Acute Repetitive Seizures Market - France
      • 7.4.4.1. France: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.5. Acute Repetitive Seizures Market - Germany
      • 7.4.5.1. Germany: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.6. Acute Repetitive Seizures Market - Italy
      • 7.4.6.1. Italy: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.7. Acute Repetitive Seizures Market - Spain
      • 7.4.7.1. Spain: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.8. Acute Repetitive Seizures Market - Netherlands
      • 7.4.8.1. Netherlands: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.4.9. Acute Repetitive Seizures Market - Russia
      • 7.4.9.1. Russia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • 7.5. Acute Repetitive Seizures Market - Asia Pacific
    • 7.5.1. Asia Pacific: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.3. Acute Repetitive Seizures Market - China
      • 7.5.3.1. China: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.4. Acute Repetitive Seizures Market - India
      • 7.5.4.1. India: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.5. Acute Repetitive Seizures Market - Malaysia
      • 7.5.5.1. Malaysia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.6. Acute Repetitive Seizures Market - Japan
      • 7.5.6.1. Japan: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.7. Acute Repetitive Seizures Market - Indonesia
      • 7.5.7.1. Indonesia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.5.8. Acute Repetitive Seizures Market - South Korea
      • 7.5.8.1. South Korea: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • 7.6. Acute Repetitive Seizures Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.6.3. Acute Repetitive Seizures Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.6.4. Acute Repetitive Seizures Market - UAE
      • 7.6.4.1. UAE: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.6.5. Acute Repetitive Seizures Market - Israel
      • 7.6.5.1. Israel: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.6.6. Acute Repetitive Seizures Market - South Africa
      • 7.6.6.1. South Africa: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • 7.7. Acute Repetitive Seizures Market - Latin America
    • 7.7.1. Latin America: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.7.3. Acute Repetitive Seizures Market - Mexico
      • 7.7.3.1. Mexico: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.7.4. Acute Repetitive Seizures Market - Brazil
      • 7.7.4.1. Brazil: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
    • 7.7.5. Acute Repetitive Seizures Market - Argentina
      • 7.7.5.1. Argentina: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. ALEXZA
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Alexza Pharmaceuticals
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Bausch Health Companies Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Neurelis, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Pfizer Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Sanofi
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. UCB S.A. Belgium
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Valeant Pharmaceuticals North America LLC.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. VERITON PHARMA
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development

List of Tables

  • Table 1 Global Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 2 Global Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Acute Repetitive Seizures Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 5 North America: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 6 U.S.: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 8 Canada: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 10 Europe: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 12 UK: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 13 UK: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 14 France: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 15 France: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Germany: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 18 Italy: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 20 Spain: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Russia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 28 China: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 China: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 30 India: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 31 India: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Japan: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 38 South Korea: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 44 UAE: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 46 Israel: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 48 South Africa: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 50 Latin America: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Mexico: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Brazil: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)
  • Table 56 Argentina: Acute Repetitive Seizures Market, by End Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Acute Repetitive Seizures Market, by Product, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Acute Repetitive Seizures Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End Use
  • Figure 7 Global Acute Repetitive Seizures Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Product
  • Figure 9 Global Acute Repetitive Seizures Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10 Acute Repetitive Seizures Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Acute Repetitive Seizures Market